Thiopurine methyltransferase (TPMT) catalyzes thiopurine S-methylation
, an important metabolic pathway for drugs such as 6-mercaptopurine (6
-MP). Inherited differences in the activity of this enzyme are related
to individual differences in the therapeutic efficacy and toxicity of
6-MP and other thiopurine drugs. Variation of TPMT activity in the re
d blood cell (RBC) has been found to reflect activity differences in l
ess accessible tissues. Previously reported qualitative analyses of in
heritance of RBC TPMT in families suggested that a major gene plays a
role in the regulation of activity of this enzyme. In the present stud
y we completed complex segregation analyses of RBC TPMT activity of 21
3 individuals in 49 families that were randomly ascertained through ch
ildren in the Rochester, MN, public school system. We found clear evid
ence of a major gene effect on RBC TPMT activity. Both transformed and
untransformed data supported the segregation of a Mendelian major gen
e with frequency of 0.94 for the allele conferring high enzyme activit
y. The genotype distributions of individuals who were homozygous for t
he low activity allele, heterozygous, and homozygous for the high acti
vity allele accounted for approximately 0.3%, 11.2%, and 88.5%, respec
tively, of the individuals in the sample. This major locus accounted f
or 66% of the total variance in untransformed RBC TPMT activity. Altho
ugh there were significant residual family correlations among probable
high activity homozygotes, there was insufficient power to detect add
itional major locus ol polygenic inheritance effects on the residual v
ariance. (C) 1995 Wiley-Liss, Inc.